Crossref
Thrombopoietin Receptor Agonists are Effective in Treating Chemotherapy-induced Thrombocytopenia in Patients with Gliomas Undergoing Myelotoxic Treatment
Oncomedicine · 2017
DOI: 10.7150/oncm.17909 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncomedicine, 2017. Verfasst von Christopher Dardis und 2 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Dardis, C., Milton, K., & Patel, N. (2017). Thrombopoietin Receptor Agonists are Effective in Treating Chemotherapy-induced Thrombocytopenia in Patients with Gliomas Undergoing Myelotoxic Treatment. Oncomedicine. https://doi.org/10.7150/oncm.17909
Vancouver
Dardis C, Milton K, Patel N. Thrombopoietin Receptor Agonists are Effective in Treating Chemotherapy-induced Thrombocytopenia in Patients with Gliomas Undergoing Myelotoxic Treatment. Oncomedicine. 2017. doi:10.7150/oncm.17909
BibTeX
@article{Dardis2017,
author = {Dardis, Christopher and Milton, Kelly and Patel, Neel},
title = {Thrombopoietin Receptor Agonists are Effective in Treating Chemotherapy-induced Thrombocytopenia in Patients with Gliomas Undergoing Myelotoxic Treatment},
journal = {Oncomedicine},
year = {2017},
doi = {10.7150/oncm.17909}
}
EUVIMED